MSK Paul Calabresi Career Development Award for Clinical Oncology

MSK Paul Calabresi 临床肿瘤学职业发展奖

• 批准号: 9788288
• 负责人: Renier Joseph Brentjens
• 金额: $ 80.8万
• 依托单位: SLOAN-KETTERING INST CAN RESEARCH
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-09-04 至 2020-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9788288
• 关键词: Advisory Committees; Applications Grants; Appointment; Award; Cancer Biology; Clinical; Clinical Oncology; Clinical Trials; Development; Educational Curriculum; Faculty; Funding; Institution; Internet; Internships; K-Series Research Career Programs; Malignant Neoplasms; Master' s Degree; Medicine; Memorial Sloan-Kettering Cancer Center; Mentors; Positioning Attribute; Process; Program Reviews; Research; Rotation; SECTM1 gene; Schools; Science; Training; Training Programs; Translational Research; United States National Institutes of Health; Visit; anticancer research; base; clinical investigation; design; programs; symposium

 DESCRIPTION (provided by applicant): This is a revised K12 application for the Paul Calabresi Career Development Award for Clinical Oncology to set up a training program for clinical translational research at Memorial Sloan Kettering Cancer Center (MSK). We propose to establish a uniquely universal training program to expand over all departments engaged in cancer research at the institution. We have designed this proposed training program to be restricted to candidates with an MD or DO degree alone. This program will provide 3 years of junior faculty funding to selected scholars. The program will solicit applications from senior fellows moving into junior faculty positions and junior faculty within the first 3 years of their appointments at MSK as well as similarly qualified candidates from other training programs through an internet-based application process. Applications for this program will be reviewed by the K12 internal advisory committee who will judge the merits of the applicants and select the 3-4 best applicants annually. Additional funding to support a program of 12 scholars annually in years 4 and 5 of the award will be provided through guaranteed matched funding support by MSK. Applications from scholars selected by the advisory committee will subsequently be evaluated by an established K12 educational committee who will design a personalized curriculum for each selected candidate. This curriculum will include a pre-established core curriculum requisite for all scholars with additional elective courses derived from available courses offered by the Louis V. Gerstner Graduate School of Biomedical Science. Significantly, over the first year of funding from this award, the K12 educational committee will establish a Master's Degree in Clinical Investigation to be awarded to all scholars who successfully complete the program. The core curriculum will include the the Cornell CTSC, curriculum, MSK cancer biology and cancer medicine courses, as well as level I mentored grant application and level II NIH R class grant application training programs. Additionally the core curriculum will include training in clinical trial development, and for 2nd and 3rd year scholars, rotational 6 month internships on relevant MSK clinical trial approval committees. The program progress will be evaluated monthly by a K12 internal advisory committee as well as an established external advisory committee who will evaluate the program every six months including an onsite visit during the planned annual K12 research symposium. Similarly, K12 scholars will be asked to review the program and their mentors every 6 months.

 描述（由申请人提供）：这是保罗·卡拉布雷西临床肿瘤学职业发展奖的修订版 K12 申请，旨在在纪念斯隆·凯特琳癌症中心 (MSK) 设立临床转化研究培训计划。培训计划扩展到该机构从事癌症研究的所有部门。我们设计了这个拟议的培训计划，仅限于仅拥有医学博士学位或博士学位的候选人。该计划将为选定的初级教师提供 3 年的资助。该计划将通过基于互联网的申请流程向在 MSK 任命后的前 3 年内晋升为初级教师职位的高级研究员以及来自其他培训计划的类似合格候选人征求申请。将由 K12 内部顾问委员会进行审查，该委员会将评判申请人的优点，并每年选出 3-4 名最佳申请人。每年将通过担保提供额外资金，以支持该奖项第 4 年和第 5 年的 12 名学者项目。配套资金支持MSK 顾问委员会选出的学者的申请随后将由一个既定的 K12 教育委员会进行评估，该委员会将为每位选定的候选人设计个性化课程。该课程将包括所有学者所需的预先制定的核心课程，并衍生出额外的选修课程。值得注意的是，在该奖项资助的第一年，K12 教育委员会将设立临床研究硕士学位，授予所有成功完成学业的学者。该计划的核心课程将包括康奈尔大学 CTSC 课程、MSK 癌症生物学和癌症医学课程，以及一级指导资助申请和二级 NIH R 类资助申请培训计划。此外，核心课程还将包括临床培训。试验开发，对于第二年和第三年的学者，在相关 MSK 临床试验批准委员会轮流实习 6 个月 该项目的进展情况将由 K12 内部咨询委员会以及已建立的外部咨询委员会每月进行评估，该委员会将每月评估该项目。六同样，K12 学者将被要求每 6 个月审查该项目及其导师。